通过综合个性化生活方式干预改善心房移的结果:随机对照试验
Jasper Vermeer1,2, Tineke Vinck-de Greef1, Maarten van den Broek1
1Department of Cardiology, Catharina Hospital Eindhoven, the Netherlands.
European heart journal
|August 30, 2025
概括
一个由护士领导的生活方式计划显著减少了重复心房动 (AF) 的减减和心脏转变. 这种综合方法改善了AF导管切除的患者的治疗结果.
科学领域:
- 心脏病学
- 电生理学
- 预防医学
背景情况:
- 生活方式因素与心房动 (AF) 导管切除的不良结果有关.
- 解决这些风险因素对于改善 AF 切除成功率至关重要.
研究的目的:
- 评估护士领导的综合生活方式方案对AF导管切除结果的有效性.
- 评估生活方式修改对重复切除和切除后心脏转变的影响.
主要方法:
- 一项前性随机对照试验 (POP-AF) 将标准护理与由护士领导的综合生活方式诊所进行了比较.
- 生活方式干预包括睡眠呼吸暂停测试,减肥/饮酒,戒烟以及高血压/高胆固醇的治疗.
- 主要终点是肺静脉隔离 (PVI) 后多次切除和心脏转移的组合.
主要成果:
- 综合生活方式治疗 (ILT) 组 (75名患者) 与对照组 (70名患者) 相比,主要终点减少了49%.
- 在ILT组中,重复切除的发生率明显较低 (RR 0. 43).
- 在ILT组中,直流心转率也减少了一半以上 (RR0. 52).
结论:
- 切除前的整合生活方式修改有效地将12个月内重复切除和心脏转换减半.
- 护士领导的生活方式干预是提高AF导管切除结果的有价值的策略.
更多相关视频
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Dysrhythmias VI: Management of Dysrhythmias
106
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Hypertension IV: Drug Therapy and Lifestyle Modifications
37
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
37


